4.6 Review

Targeting CXCR4 in AML and ALL

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia

Yiqian Wang et al.

CANCER GENE THERAPY (2020)

Review Biochemistry & Molecular Biology

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells

Ina Nepstad et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Bone marrow niches in haematological malignancies

Simon Mendez-Ferrer et al.

NATURE REVIEWS CANCER (2020)

Review Chemistry, Medicinal

Radionuclide- Labeled Peptides for Imaging and Treatment of CXCR4-Overexpressing Malignant Tumors

Nan Liu et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation

Sabine Maurer et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Review Hematology

Normal and leukemic stem cell niche interactions

Il-Hoan Oh et al.

CURRENT OPINION IN HEMATOLOGY (2019)

Article Medicine, Research & Experimental

BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment

Sujan Piya et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Pharmacology & Pharmacy

Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3

Joyce Heuninck et al.

MOLECULAR PHARMACOLOGY (2019)

Review Medicine, General & Internal

Clinical and Therapeutic Implications of Cancer Stem Cells

Michael F. Clarke

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

The cell of origin and the leukemia stem cell in acute myeloid leukemia

Martin Chopra et al.

GENES CHROMOSOMES & CANCER (2019)

Review Pharmacology & Pharmacy

Modulators of CXCR4 and CXCR7/ACKR3 Function

Ilze Adlere et al.

MOLECULAR PHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

Vladimir Bobkov et al.

MOLECULAR PHARMACOLOGY (2019)

Article Medicine, Research & Experimental

[68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4

Joseph Lau et al.

MOLECULAR PHARMACEUTICS (2019)

Article Multidisciplinary Sciences

C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4

Kentaro Suzuki et al.

SCIENTIFIC REPORTS (2019)

Review Biochemistry & Molecular Biology

Targeting PI3K Signaling in Acute Lymphoblastic Leukemia

Vanessa Edna Sanchez et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

Maria Jose Costa et al.

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies

Amnon Peled et al.

CYTOKINE (2018)

Review Pharmacology & Pharmacy

ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway

Andrew M. Kidger et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Medicine, Research & Experimental

Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics

Stefan Habringer et al.

THERANOSTICS (2018)

Review Pharmacology & Pharmacy

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy

Feifei Liu et al.

ACTA PHARMACEUTICA SINICA B (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

CXCR4-directed theranostics in oncology and inflammation

Malte Kircher et al.

ANNALS OF NUCLEAR MEDICINE (2018)

Review Oncology

New Approaches to the Management of Adult Acute Lymphoblastic Leukemia

Renato Bassan et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Biased antagonism of CXCR4 avoids antagonist tolerance

Ben Hitchinson et al.

SCIENCE SIGNALING (2018)

Article Cell & Tissue Engineering

Peripheral Blood Stem Cell Mobilization: a Look Ahead

Louis M. Pelus et al.

CURRENT STEM CELL REPORTS (2018)

Review Biochemistry & Molecular Biology

The hematopoietic stem-cell niche in health and leukemia

Abel Sanchez-Aguilera et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Hematology

New agents in HSC mobilization

Meanie Domingues et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

Article Medicine, Research & Experimental

[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

Margret Schottelius et al.

THERANOSTICS (2017)

Review Medicine, General & Internal

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside

Byung-Sik Cho et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2017)

Review Immunology

Pathophysiology of GvHD and Other HSCT-Related Major Complications

Sakhila Ghimire et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Review Hematology

Emerging therapeutic drugs for AML

Eytan M. Stein et al.

Review Biochemistry & Molecular Biology

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting

Francesca Chiarini et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)

Review Pharmacology & Pharmacy

Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma

Federica Barbieri et al.

EXPERT OPINION ON DRUG DISCOVERY (2016)

Article Medicine, General & Internal

Adult Acute Lymphoblastic Leukemia

Shilpa Paul et al.

MAYO CLINIC PROCEEDINGS (2016)

Article Cell & Tissue Engineering

Cell Adhesion Molecules in Normal and Malignant Hematopoiesis: from Bench to Bedside

Jean-Pierre Levesque et al.

CURRENT STEM CELL REPORTS (2016)

Review Oncology

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Ching-Hon Pui et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Oncology

Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia

Geoffrey L. Uy et al.

LEUKEMIA RESEARCH (2015)

Article Medicine, Research & Experimental

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

Hans Juergen Wester et al.

THERANOSTICS (2015)

Article Chemistry, Multidisciplinary

A CXCR4-Targeted Site-Specific Antibody-Drug Conjugate

Sumith A. Kularatne et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)

Article Hematology

Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia

Lieke C. J. van den Berk et al.

BRITISH JOURNAL OF HAEMATOLOGY (2014)

Article Medical Laboratory Technology

CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia

Francesco Mannelli et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2014)

Article Cell Biology

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy

Aldo M. Roccaro et al.

CELL REPORTS (2014)

Article Biochemical Research Methods

CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands

C. Castaldo et al.

JOURNAL OF BIOMOLECULAR SCREENING (2014)

Review Oncology

A review on CXCR4/CXCL12 axis in oncology: No place to hide

Urszula M. Domanska et al.

EUROPEAN JOURNAL OF CANCER (2013)

Article Hematology

Is the post-transplantation treatment with AMD beneficial?

Yi Jiang et al.

BLOOD CELLS MOLECULES AND DISEASES (2012)

Article Hematology

Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)

Manali V. Joglekar et al.

THROMBOSIS AND HAEMOSTASIS (2012)

Article Anatomy & Morphology

The Prognostic Value of CXCR4 in Acute Myeloid Leukemia

Jeong Yeal Ahn et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)

Review Oncology

Modern Therapy of Acute Lymphoblastic Leukemia

Renato Bassan et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Multidisciplinary Sciences

Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles

Sergey G. Tarasov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Oncology

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

Beverly A. Teicher et al.

CLINICAL CANCER RESEARCH (2010)

Article Multidisciplinary Sciences

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

William Blum et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Pharmacology & Pharmacy

The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)

Erik De Clercq

BIOCHEMICAL PHARMACOLOGY (2009)

Article Oncology

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia

Emmanuelle Tavernier-Tardy et al.

LEUKEMIA RESEARCH (2009)

Article Hematology

CXCR4 is a prognostic marker in acute myelogenous leukemia

Anke C. Spoo et al.

Article Biochemistry & Molecular Biology

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

H Tamamura et al.

FEBS LETTERS (2004)

Article Medicine, General & Internal

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

B Löwenberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)